Healthcare Organizations Must Revisit AI Data Clauses to Protect Valuable Assets

In the rapidly evolving landscape of artificial intelligence (AI) in healthcare, data is more valuable than ever. Organizations are increasingly leveraging AI to enhance patient care, streamline operations, and drive innovation. However, a critical oversight can turn this asset into a liability: poorly constructed data clauses in contracts. According to Anne Elise Herold Li, managing partner and shareholder at Brownstein Hyatt Farber Schreck, healthcare organizations must revisit these clauses immediately to protect their valuable data.

The importance of data in AI training cannot be overstated. High-quality, well-structured data is the lifeblood of effective AI models. However, many organizations inadvertently cede control over this crucial resource through vague or overly permissive data clauses in contracts with third-party vendors. These clauses can expose healthcare providers to significant risks, including data breaches, intellectual property theft, and regulatory non-compliance.

Why it Matters

The implications of poorly constructed data clauses are far-reaching. For instance, a clause that allows a vendor to use patient data for unspecified purposes can lead to the data being used in ways that were not originally intended or agreed upon. This could result in legal action from patients, fines from regulatory bodies, and damage to the organization's reputation. If the data is used to train AI models that are then sold to competitors, it can undermine a healthcare provider's competitive advantage.

Herold Li highlights a specific example where a healthcare organization signed a contract with an AI vendor without fully understanding the implications of the data clause. The clause allowed the vendor to use the data for "research and development purposes," which was interpreted broadly to include training new AI models that were later sold to other healthcare providers, including direct competitors. This not only compromised patient privacy but also diluted the value of the organization's proprietary data.

The risks are not limited to legal and ethical concerns. Financially, poorly managed data can lead to significant losses. According to a report by Ponemon Institute, the average cost of a data breach in healthcare is $429 per record, one of the highest across all industries. In 2022 alone, the healthcare sector experienced over 700 reported data breaches, affecting millions of patients and costing organizations billions of dollars.

Investment Implications

For investors, the risks associated with poorly managed data clauses can have a direct impact on the valuation and long-term prospects of AI startups in the healthcare space. Venture capitalists (VCs) are increasingly scrutinizing these clauses as part of their due diligence process. Startups that fail to protect their data effectively may find it difficult to attract investment, secure partnerships, or achieve favorable valuations.

A recent survey by CB Insights found that 78% of VCs consider data security and privacy a critical factor when evaluating healthcare AI startups. This trend is likely to continue as regulatory scrutiny increases. For instance, the European Union's General Data Protection Regulation (GDPR) and the California Consumer Privacy Act (CCPA) impose strict requirements on how organizations handle personal data, with significant penalties for non-compliance.

Investors are looking for startups that can demonstrate a clear understanding of data governance and a robust framework for managing data throughout its lifecycle. This includes not only securing data at rest and in transit but also ensuring that data is used ethically and transparently. Startups that prioritize these aspects are more likely to gain the trust of both investors and customers.

Healthcare organizations must take proactive steps to revisit and strengthen their data clauses in contracts with AI vendors. This is not just a legal necessity but a strategic imperative for protecting valuable assets, maintaining competitive advantage, and ensuring long-term success. For investors, supporting startups that prioritize data security and governance can yield significant returns while mitigating potential risks.